Stockreport

Tarsus Pharmaceuticals: A Strong Launch For An Under The Radar Name [Seeking Alpha]

Tarsus Pharmaceuticals, Inc.  (TARS) 
PDF TARS plans to discuss the path forward in these new indications with the US Food and Drug Administration. TARS has also reported sales of $13.1M from the first full q [Read more]